This study involves giving psychoactive drugs intramuscularly (injected into the muscle of the upper arm or the hip) and/or orally, and measuring the subject's ability to tell the difference between one drug and another, as well as measuring the effects of the drugs on mood, physiology (e.g., heart rate, blood pressure, respiration rate) and behavior. Each subject will receive 2-4 of the listed interventions.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
DOUBLE
Enrollment
40
Cycloserine: 500, 675, 750 mg oral capsule may possibly be given
Diltiazem: 30, 60, 120 mg oral capsule may possibly be
Gabapentin: 100, 200, 400 mg oral capsule may possibly be given
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Drug Discrimination Measure
Time frame: Every session
Self-reported effects
Time frame: Every Session
Vital Signs
Time frame: Every session
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Isradipine: 5, 10 mg oral capsule may possibly be given
Naloxone: 0.15 mg/70 kg or 0.2 mg I.M. injection may possibly be given
Nifedipine: 5, 10, 20 mg oral capsule may possibly be given
Placebo (sugar pill or microcrystalline cellulose): oral capsule may possibly be given
Saline: I.M. injection may possibly be given
Verapamil: 30, 60, 120 mg oral capsule may possibly be given